March 12, 2024, 4:42 a.m. | Thomas P. Wytock, Adilson E. Motter

cs.LG updates on arXiv.org arxiv.org

arXiv:2403.04837v1 Announce Type: cross
Abstract: Recent developments in synthetic biology, next-generation sequencing, and machine learning provide an unprecedented opportunity to rationally design new disease treatments based on measured responses to gene perturbations and drugs to reprogram cells. The main challenges to seizing this opportunity are the incomplete knowledge of the cellular network and the combinatorial explosion of possible interventions, both of which are insurmountable by experiments. To address these challenges, we develop a transfer learning approach to control cell behavior …

abstract arxiv biology cells challenges cond-mat.dis-nn cs.lg design disease drugs functional gene knowledge machine machine learning networks next q-bio.gn q-bio.mn responses sequencing synthetic synthetic biology transfer transfer learning type

Data Architect

@ University of Texas at Austin | Austin, TX

Data ETL Engineer

@ University of Texas at Austin | Austin, TX

Lead GNSS Data Scientist

@ Lurra Systems | Melbourne

Senior Machine Learning Engineer (MLOps)

@ Promaton | Remote, Europe

Risk Management - Machine Learning and Model Delivery Services, Product Associate - Senior Associate-

@ JPMorgan Chase & Co. | Wilmington, DE, United States

Senior ML Engineer (Speech/ASR)

@ ObserveAI | Bengaluru